Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Charles River Laboratories to Present at September Investor Conferences By: Charles River Laboratories International, Inc. via Business Wire News Releases August 30, 2018 at 16:37 PM EDT Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including: Wells Fargo 2018 Healthcare Conference in Boston on Wednesday, September 5th, at 9:40 a.m. ET; Baird 2018 Global Healthcare Conference in New York on Thursday, September 6th, at 10:15 a.m. ET; and Morgan Stanley 16th Annual Global Healthcare Conference in New York on Thursday, September 13th, at 10:00 a.m. ET. Management will provide an overview of Charles River’s strategic focus and business developments. A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks. About Charles River Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20180830005838/en/ Contacts: Charles River Laboratories International, Inc.Investor Relations Contact:Todd Spencer, 781-222-6455Corporate Vice President, Investor Relationstodd.spencer@crl.com Related Stocks: Charles River Laboratories Intl Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Charles River Laboratories to Present at September Investor Conferences By: Charles River Laboratories International, Inc. via Business Wire News Releases August 30, 2018 at 16:37 PM EDT Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at three upcoming investor conferences, including: Wells Fargo 2018 Healthcare Conference in Boston on Wednesday, September 5th, at 9:40 a.m. ET; Baird 2018 Global Healthcare Conference in New York on Thursday, September 6th, at 10:15 a.m. ET; and Morgan Stanley 16th Annual Global Healthcare Conference in New York on Thursday, September 13th, at 10:00 a.m. ET. Management will provide an overview of Charles River’s strategic focus and business developments. A live webcast of each presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after each presentation and will remain available for approximately two weeks. About Charles River Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20180830005838/en/ Contacts: Charles River Laboratories International, Inc.Investor Relations Contact:Todd Spencer, 781-222-6455Corporate Vice President, Investor Relationstodd.spencer@crl.com Related Stocks: Charles River Laboratories Intl